Individualized Wellness Solutions
REAL Medicine Services
Our Services
Discover treatment options built around your unique goals, helping you achieve lasting energy, balance, and well-being.
REAL Medicine Services
We believe lasting wellness comes from treating the whole person – body, mind, and hormone balance. At REAL Medicine, our services are designed to uncover the root causes behind your symptoms and restore lasting energy, clarity, and confidence. From personalized hormone therapy to thyroid optimization and metabolic health pathways, every treatment plan is tailored to your unique needs and goals.
Our Core Services
Comprehensive, science-based care tailored to your unique needs for lasting energy and well-being.
Metabolic Health
Customized pathways to enhance metabolic function and achieve your health goals, featuring evidence-based options such as GLP therapies.
Thyroid & Comprehensive Health
Thorough evaluation of your overall wellness, including a complete thyroid analysis and cardiac risk profile, to identify and address underlying imbalances.
Hormone Therapy
Personalized care for perimenopausal and menopausal symptoms through the use of bioidentical hormones and nonhormonal treatments tailored to your individual needs.
Menopause
Menopause is defined as the permanent cessation of menstrual periods, diagnosed retrospectively after 12 consecutive months of amenorrhea not attributable to other causes, and is accompanied by a profound and permanent decrease in ovarian estrogen synthesis. The average age of natural menopause is around 51 years, though it can occur earlier (before age 45 is considered early, and before age 40 is considered premature). Menopause can also be induced surgically (bilateral oophorectomy) or by medical treatments such as chemotherapy, but in these cases, additional hormonal testing (FSH and estradiol) may be required to confirm menopausal status, especially in patients with breast cancer or those on medications that affect ovarian function.
Perimenopause
Perimenopause is defined as the transitional period leading up to menopause, characterized by variable menstrual cycles, hormonal fluctuations, and the onset of menopause-related symptoms, and it extends through the first year after the final menstrual period. This phase typically begins with changes in menstrual cycle regularity (such as a persistent difference of ≥7 days in cycle length or episodes of amenorrhea ≥60 days) and includes symptoms like vasomotor instability, mood changes, and genitourinary complaints. The perimenopausal period can last several years, with the average onset around age 45–47 and a mean duration of 3.8–6.25 years.
Hypothyroidism
Hypothyroidism is a clinical syndrome resulting from insufficient production or action of thyroid hormones, most commonly due to primary failure of the thyroid gland. It is diagnosed biochemically by an elevated thyroid-stimulating hormone (TSH) level and a low free thyroxine (T4) level (overt hypothyroidism) and low free T3 levels; subclinical hypothyroidism is defined by elevated TSH with normal free T4 levels.
Primary hypothyroidism accounts for over 99% of cases and is most often caused by chronic autoimmune thyroiditis (Hashimoto’s thyroiditis). Symptoms are often nonspecific and related to metabolic slowing: fatigue, weight gain, cold intolerance, constipation, dry skin, bradycardia, cognitive impairment, and menstrual irregularities are common.
Insulin Resistence
Insulin resistance is defined as a pathological state in which target tissues—primarily skeletal muscle, adipose tissue, and liver—exhibit a diminished biological response to normal or elevated concentrations of insulin, resulting in impaired glucose uptake, utilization, and storage, and often leading to compensatory hyperinsulinemia and metabolic disturbances. Insulin resistance is typically associated with obesity, chronic inflammation, lipotoxicity, and genetic predisposition, but can also occur in normal-weight individuals. It is clinically important because it precedes and contributes to the development of type 2 diabetes and increases the risk for cardiovascular disease and other metabolic complications.